Wealthy medieval Christians often purchased graves near churches, which stood at the center of medieval cities. They were elevated, fortified, and central landmarks. These features made burial plots near churches desirable and costly.

Researchers wondered whether disease stigma changed burial access. They studied whether illness kept affluent people from prime graves. Scientists focused their data collection on medieval Denmark. There, close proximity to churches clearly signaled wealth and status. Surprisingly, the findings showed that wealth insulated some Christians from disease stigma. Their riches allowed them access to preferable burial sites regardless of their visible diseases.

[Read more…]

Antimicrobial resistance (AMR) is like a mutant monster straight out of a science-fiction movie. With each new attack, the creature generates new defenses, becoming harder to kill. Except rather than one giant monster, the creature takes the shape of billions of microbes.

AMR is one of the most pressing issues in global health today. The more antibiotics health professionals use to fight bacteria, the more bacteria resist them. The World Health Organization (WHO) describes AMR as an immediate threat. Recent data shows resistance increasing 5-15% year-over-year. Researchers estimate over 10 million deaths from AMR may occur each year by 2050.

[Read more…]

An army that can turn itself into a guerilla force is easy to underestimate. That failure would be perilous, as the enemies turn an initial invasion into an underground retreat. The guerrillas could continue to hide out for decades, causing continual harm. Having carved out their hiding places, such a force would be very difficult to root out.

Chikungunya virus (CHIKV) mimics the activity of such a subversive invading army. After initial infection, CHIKV burrows deep into musculoskeletal and joint tissues. Most patients recover from the first wave of symptoms. These include fever, rash, and joint and muscle pain. Even after getting over the initial illness, chronic joint inflammation can persist for years.

Researchers developed a new vaccine that imitates CHIKV activity at safe levels. This mimicry prepares the immune system for incoming viral threats. Closing the gap on a widely available vaccine is essential as CHIKV causes increasing outbreaks.

[Read more…]

Imagine a zombie that falls apart when killed. Instead of simply dying, parts of its body continue to attack, overwhelming the defender. COVID-19 cells exhibit similar behavior when the immune system destroys them. Instead of simply staying dead, the cell’s remaining proteins go on the hunt for immune cells.

This monstrous ability may help explain the prolonged symptoms COVID-19 infections can cause. The continued harm of dead COVID-19 cell proteins might also explain Long COVID symptoms in some cases.

[Read more…]

Long COVID remains difficult to diagnose and treat with full confidence. Symptoms vary widely between patients and across proposed explanations. This variability makes the illness harder to define clinically. It also fuels stigma and skepticism when patients seek care.

New research from Northwestern University adds complexity to this challenge. Researchers analyzed self-reported data from 3,100 Long COVID patients. The study examined symptom patterns across multiple countries. Its findings highlight major differences in reported neurological and mental health symptoms.

[Read more…]

As billionaires and wellness influencers chase longevity hacks, new research points elsewhere. Evidence continues to grow that vaccines support longer, healthier lives. New findings show the shingles vaccine may slow biological aging in older adults.

The research was published in The Journals of Gerontology: Series A. It adds to earlier work linking vaccination to reduced disease and mortality. This study focuses specifically on biological aging processes, not lifespan alone.

Researchers analyzed data from the U.S. Health and Retirement Study. The dataset included nearly 4,000 adults aged 70 years and older. Participants were tracked using extensive health, biomarker, and survey data.

[Read more…]

For years, Toxoplasma gondii was framed like a horror-movie parasite. It lurks inside millions of human brains without obvious warning. About forty million people in the United States carry this parasite.

New research does not soften that unsettling picture. Instead, it reveals a parasite far more active than previously believed. Scientists now see signs of coordination, adaptation, and long-term strategy.

Researchers from University of California, Riverside uncovered this hidden complexity. Their findings suggest T. gondii is not quietly dormant inside the body. Instead, it remains organized and responsive while evading immune detection.

[Read more…]

Nothing works forever without gradual decline. Machines wear down, and clothing thins with repeated use. The immune system follows this same pattern as people age.

As humans grow older, immune defenses steadily weaken over time. This decline increases vulnerability to infections, cancer, and chronic disease. Researchers now report a potential method to restore immune function later in life.

New research suggests immune decline may not be permanent or unavoidable. Scientists identified a way to revive key immune activity in aging mice. The findings point toward future treatments supporting healthier immune aging.

[Read more…]

A major mistake in any fight is underestimating a dangerous opponent. Researchers now warn the public about obscure microbes called free-living amoebas. These pathogens are extremely hard to kill and increasingly common worldwide.

Free-living amoebas naturally thrive in soil, freshwater, and many water systems. They survive intense heat, chlorine exposure, and harsh chemical water treatments. This resilience allows them to persist where other microbes would die.

[Read more…]

One of the most difficult challenges with COVID-19 is constant viral evolution. As the virus mutates and infects animals, tracking its changes becomes harder. Current vaccines remain the strongest defense against severe COVID-19 disease. Still, improved vaccine technologies are urgently needed as variants continue emerging.

Researchers recently tested a single-dose intranasal COVID-19 vaccine in animals. They found it effectively prevented coronavirus infection and blocked viral transmission. The research team comes from the University of Hong Kong’s LKS Faculty of Medicine. Their work focuses on preventing future coronavirus outbreaks before they spread.

This new vaccine functions like a Swiss Army knife against coronaviruses. Most existing vaccines primarily protect against one dominant viral strain. This prototype offers broad protection and requires only a single dose.

[Read more…]